SHAUN GUNDERSEN: Open Payments
NPI 1659721934 · GRANTSVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 67 payments from 20 companies in 2025. Trend: 2023 $794 · 2024 $922 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $216 |
| Otsuka America Pharmaceutical, Inc. | 17 | $168 |
| Medtronic, Inc. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Astellas Pharma US Inc | 3 | $69 |
| Amgen Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| Exact Sciences Corporation | 3 | $57 |
| Lundbeck LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: REXULTI, VRAYLAR, MINIMED 780G, CAPLYTA, Veozah, EVENITY, Cologuard Collection Kit, Symbravo.
Industry payments across UT — which companies pay providers there.
